tm
Seeing Is Believing
tm
Seeing Is Believing
Progenics Pharmaceuticals's activity chart (see below) currently has 32 price targets and 24 ratings on display.
Analysts average stock forecasts to be materialized ratio is 37.41% with an average time for these price targets to be met of 128.75 days.
Most recent stock forecast was given by from CAPITAL ONE on 12-Aug-2019. First documented stock forecast 12-Mar-2008.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Aug-2019
$14
$9.9 (241.46%)
$14
7 years 2 months 10 days ago
(12-Aug-2019)
0/2 (0%)
$10.1 (258.97%)
Buy Since 30-Sep-2014
$10
$5.9 (143.90%)
7 years 7 months 8 days ago
(14-Mar-2019)
5/11 (45.45%)
$5.58 (126.24%)
295
Buy Since 23-Oct-2015
$13
$8.9 (217.07%)
$11
9 years 7 months 12 days ago
(09-Mar-2017)
3/4 (75%)
$1.52 (13.24%)
188
Buy Since 04-Oct-2016
$11
$6.9 (168.29%)
$11
9 years 11 months 26 days ago
(26-Oct-2016)
2/2 (100%)
$5.85 (113.59%)
135
Buy Since 06-Aug-2015
$14
$9.9 (241.46%)
$14
10 years 3 months 2 days ago
(20-Jul-2016)
1/4 (25%)
$7.86 (128.01%)
76
What is PGNX (Progenics Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on PGNX (Progenics Pharmaceuticals)?
Which analyst has the current lower performing score on PGNX (Progenics Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PGNX (Progenics Pharmaceuticals)?
Which analyst is the currently most bullish on PGNX (Progenics Pharmaceuticals)?
Which analyst is the currently most reserved on PGNX (Progenics Pharmaceuticals)?
